CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL · XNYS

CIK 1100682fmd_1T3CCY85NXKSSYG6CNSF7SDMSBServices · Services-Commercial Physical & Biological ResearchTemplate: Standard

Coverage: Dec 30, 2007 to Sep 26, 2026, 71 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	1,681	1,858	2,266	2,621	2,924	3,540	3,976	4,129	4,050	4,015
Cost of revenue	277	290	–	–	–	–	–	–	–	–
Gross profit	1,404	1,568	–	–	–	–	–	–	–	–
Provision for credit losses	–	–	–	–	6	2	7	–	–	–
Selling, general and administrative	365	371	444	518	529	620	665	748	751	743
Operating income	238	288	331	351	433	590	651	617	227	25
Interest expense	28	30	64	61	86	74	59	137	126	107
Interest and investment income	1	1	1	2	1	1	1	5	9	5
Other non-operating income (expense)	12	38	13	12	100	(36)	31	96	(17)	(23)
Income before taxes	223	297	282	304	447	481	623	581	93	(100)
Income tax expense	67	171	54	50	82	82	130	101	68	43
Net income from continuing operations	156	126	227	254	365	399	493	480	25	(142)
Net income	155	123	226	252	364	391	486	475	22	(144)
Net income to common shareholders	–	–	–	–	–	–	486	475	10	(144)